Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01338987
Title Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

bone marrow cancer

acute lymphoblastic leukemia

Therapies

Tacrolimus

Busulfan

Methotrexate

Leuprolide

Cyclophosphamide

Fludarabine

Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Childrens National Medical Center Washington District of Columbia 20010 United States Details
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland 20892 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field